Skip to content

The Real-World Study on Optimizing the Intervention Strategy of Sanfu Patch for Pediatric Asthma Prevention and Treatment and the Construction of Chronic Disease Management Models.

The Real-World Study on Optimizing the Intervention Strategy of Sanfu Patch for Pediatric Asthma Prevention and Treatment and the Construction of Chronic Disease Management Models.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002353
Enrollment
Unknown
Registered
2025-11-28
Start date
2026-05-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Control Group:Standard Care Group without Sanfu Patch
Control Group:The intervention group will receive Sanfu patch treatment during the non-acute phase of asthma.

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1.Meeting both traditional Chinese medicine (TCM) and Western medicine diagnostic criteria for asthma; 2.Children in the chronic persistent stage or clinical remission stage according to Western medicine; 3.Children in the remission-migration stage or remission stage according to TCM; 4.Aged 3–14 years and able to cooperate with the full course of treatment; 5.Not participating in other clinical studies; 6.Informed consent obtained from the child's parents or other legal guardians.

Exclusion criteria

Exclusion criteria: 1.Children in the acute attack phase of asthma; 2.Children with asthma complicated by severe diseases of the heart, liver, kidneys, hematopoietic system, neuromuscular system, spinal deformities, or other systemic conditions that may lead to abnormal pulmonary function; 3.Children currently undergoing other treatment regimens outside this study; 4.Children whose parents or other legal guardians decline participation; 5.Children with known allergies to any of the study medications.

Design outcomes

Primary

MeasureTime frame
Asthma Exacerbations;

Secondary

MeasureTime frame
raditional Chinese Medicine (TCM) Syndrome Score;Pulmonary Function;

Countries

China

Contacts

Public ContactZheng Xue

Shanghai Municipal Hospital of Traditional Chinese Medicine

xz695@163.com18621905133

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026